Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533.
J Clin Oncol
; 40(26): 3047-3056, 2022 09 10.
Article
in En
| MEDLINE
| ID: mdl-35580298
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Wilms Tumor
/
Circulating Tumor DNA
/
Kidney Neoplasms
Type of study:
Prognostic_studies
Limits:
Child
/
Humans
Language:
En
Journal:
J Clin Oncol
Year:
2022
Document type:
Article
Affiliation country:
Morocco
Country of publication:
United States